Indonesia IVD Market Analysis

  • ID: 4345273
  • Report
  • Region: Indonesia
  • 217 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux
  • Critical Diagnostics
  • HemoCue AB
  • Nihon Kohden Corporation
  • Radiometer Medical ApS
  • MORE

Indonesia is the 4th largest country in the world in terms of population after China, India, and USA and an important and prospective market for diagnostics and medical device manufacturers. This report was produced by Malaysia-based analysts and analysts operating in Indonesia. Market analyses in this report cover Indonesian markets for life science and clinical applications of in vitro diagnostics (IVD) technology. Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics companies participating in Indonesia's market.

Data Points Provided Include the Following:

  • Sales of Rapid Tests for Infectious Diseases by Category, Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total)
  • Microbiology Sales in Indonesia, 2017-2022 (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies, reagents, etc.]; Microbiology, Total)
  • Hematology Sales by Category, Indonesia, 2017-2022 (Hematology Systems; Hematology POC; Other [Digital imaging, analysis software, etc.]; Hematology, Total)
  • Indonesia Clinical Chemistry Market by Category, 2017-2022 (General Chemistry; Blood Gas Analyzers; Critical Care POC; Clinical Chemistry, Total)
  • Indonesia POC Market by Category, 2017-2022 (POC-Diabetes; POC-OTC/Self-Testing, Other; POC-OTC/Self Testing, Total; Cardiac Markers; DOA/Toxicology; Other; POC-Professional, Total; POC, Total)
  • Indonesia Immunoassay Market (Non-Infectious) by Category, 2017-2022 (Diabetes; Cardiac markers; Other [Cancer Markers, DOA tests; cholesterol, RIAs for thyroid, hormones, endocrine markers, etc.]; Total, Lab-based Immunoassays - Non-Infectious; DOA testing - rapid tests; Cancer markers - Rapid tests; Cardiac markers - Rapid tests; Others [Pregnancy, Cancer markers, etc.]; Total, POC - Immunoassays - Non-Infectious; Total - Immunoassays - Non-Infectious)
  • Blood Testing and Typing Sales by Category (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT), Indonesia, 2017-2022
  • Hemostasis Sales by Category (Lab-based Coagulation Tests, POC Coagulation Tests), Indonesia, 2017-2022
  • Histology Sales by Category (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC, and Flow Cytometry]), Indonesia, 2017-2022
  • Major Diseases and Demand for Lab-based Immunoassay Diagnostics in Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Lab-based Immunoassays - Infectious Diseases, Total)
  • Popular Rapid Test Brands and Their Distributors in Indonesia
  • STD Test Costs at Selected Clinics and Hospitals in Indonesia
  • Total IVD Market in Indonesia by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays - Non-Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.]), 2017-2022

The Healthcare Delivery System - Key Market Drivers and Challenges Indonesia's in vitro diagnostics market is not without challenges. However, Indonesia’s healthcare sector is set to grow rapidly in the next five years through various initiatives by government. The most important initiative is the universal health coverage (UHC) plan, which is locally known as JKN, announced in 2014. Under UHC, the government is targeting to ensure health insurance available for entire population of the country by 2019. UHC implementation is progressing at a fast pace, with investments from both private and public sectors.

Indonesia IVD Market Analysis provides the following data on the Indonesian healthcare market:

  • Indonesia Healthcare Expenditure, 2000-2014 (Total Health Expenditure as % of GDP, Public Health Expenditure, Private Health Expenditure)
  • General and Specialty Hospitals in Indonesia, 2011-2015
  • Community Healthcare Centers (CHCs) in Indonesia, 2011-2015
  • Distribution of Puskesmas (CHCs) in Indonesia across 34 Provinces
  • Selected General and Specialty Hospitals in Indonesia
  • Selected Leading Private Hospitals in Indonesia, by Province
  • Selected Private Laboratories in Indonesia
  • Indonesia Healthcare Spending Compared to Southeast Asia Neighbors (New Zealand, Japan, Australia, South Korea, Vietnam, China, Singapore, India, Malaysia, Thailand)

Options for a Foreign IVD Company to Enter the Indonesian Market In the Indonesia IVD market, foreign IVD companies are banned from making any direct sales. Only local distribution companies, who have distribution licenses, can engage in IVD sales in the country. Therefore, assistance of a local legal firm is the best way for a foreign company to set up its operations in Indonesia. The report examines the options available to a foreign IVD company looking to enter the Indonesian market.

These Include:

  • Opening an Affiliated Branch Office in Indonesia
  • Selecting a Suitable Exclusive Distributor
  • Setting up Original Equipment Manufacturer (OEM) Operations; Investing in Local Manufacturing within 3 Years

Via three case studies, business strategies adopted by multinational companies (MNCs) are examined as well.

Also included are other valuable resources regarding the regulation of IVD devices and distribution within the framework of the Indonesian IVD market:

  • Selected Foreign Companies and Their Key Distributors in Indonesia
  • Classification of Medical Devices in the Indonesian Healthcare Market
  • Processes for Distribution License, Company and Product Registrations
  • Licenses Required for IVD Distribution in Indonesia
  • Indonesia Investment Coordinating Board (BKPM) Offices

Competitive Analysis

In the Indonesian healthcare market, rapidly increasing expenditure trends hint at new market opportunities for market players and investors.

Indonesia IVD Market Analysis provides information on the major players in IVD market sub-segments, including:

  • Major Players in the Indonesian Hematology Market
  • Major Players in the Indonesian Clinical Chemistry Market
  • Major Players in the Indonesian Urinalysis Market
  • Major Players in the Indonesian Coagulation Market
  • Major Players in the Indonesian Histology Market
  • Distribution of Blood Centers in Indonesia, by Province

The report provides as well profiles of IVD companies, private labs, and distributors operating in the Indonesian IVD Market.

IVD companies profiled include:

  • Abbott Laboratories
  • Alere
  • Arkray Healthcare
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Bio-Rad
  • Cellavision
  • Cepheid
  • Critical Diagnostics
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • ERBA Diagnostics
  • HemoCue AB
  • Hologic, Inc.
  • Horiba, Ltd.
  • Instrumentation Laboratory Company
  • Luminex Corporation
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • Radiometer Medical ApS
  • Randox Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation
  • Trinity Biotech

Data is Provided on the Leading Private Labs in Indonesia, which include:

  • Laboratorium Klinik Utama Bio Medika
  • PT Cito Putra Utama
  • PT Kimia Farma Diagnostika
  • Laboratorium Klinik Pramita
  • PT Prodia Widyahusada Tbk

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas where IVD assays are used.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux
  • Critical Diagnostics
  • HemoCue AB
  • Nihon Kohden Corporation
  • Radiometer Medical ApS
  • MORE

1: Executive Summary
Introduction
Figure 1-1: Map of Indonesia, with Provinces
Figure 1-2: Total Population of Indonesia (2000-2016)
Table 1-1: GDP Growth in Indonesia, 2012-2015
Health Status Of Indonesians
Healthcare Delivery System
Regulation Of Ivd Devices And Distribution
Scope And Methodology
Size And Growth Of The Ivd Market
Figure 1-3: IVD Market in Indonesia, 2017 and 2022

2: Indonesia - A Growing IVD Market

  • Healthcare Expenditure In Indonesia
    • Figure 2-1: Growth of Health Expenditure per Capita (USD) in Indonesia, 2000-2014
    • Figure 2-2: Growth of Health Expenditure per Capita in PPP Terms (USD), Indonesia, 2000-2014
    • Health Indicators In Indonesia
    • Figure 2-3: Top 10 Causes of Death in Indonesia
    • Table 2-1: Life Expectancy and Mortality Rates in Indonesia, 2000-2014 (Life Expectancy, Total; Life Expectancy at Birth, Male; Life Expectancy at Birth, Female; Total Mortality Rate, Adult, Male; Total Mortality Rate, Adult, Female)
    • Prevalent Infectious Diseases In Indonesia
    • Tuberculosis (TB)
    • Table 2-2: Assessment of TB Burden in Indonesia, WHO
    • Table 2-3: Pulmonary Tuberculosis Cases by Province, Indonesia
    • HIV/AIDS
    • Table 2-4: The Number of New Cases of HIV and AIDS between 2011 and 2015, Indonesia
    • Table 2-5: HIV and AIDS Cases in Indonesia, by Province
    • Malaria
    • Table 2-6: Incidence of Malaria in Indonesia, by Province
    • Dengue
    • Table 2-7: Dengue Hemorrhagic Fever (DHF) Cases in Indonesia, by Province
    • Filariasis
    • Table 2-8: Filariasis in Indonesia, 2011-2015
    • Table 2-9: Filariasis Cases in Indonesia, by Province, 2012-2014
    • Leptospirosis
    • Table 2-10: Leptospirosis Cases in Indonesia, by Province, 2011-2015
    • Typhoid
    • Table 2-11: Typhoid Prevalence in Indonesia, by Province
    • Human Papilloma Virus (HPV)
  • Indonesian Healthcare Industry Landscape
    • Figure 2-4: Healthcare Delivery in Indonesia
    • Healthcare Delivery System
    • Public Healthcare System: General and Specialty Hospitals
    • Table 2-12: General and Specialty Hospitals in Indonesia, 2011-2015
    • Public Healthcare System: Community Healthcare Centers (CHCs/Puskesmas)
    • Table 2-13: Community Healthcare Centers in Indonesia, 2011-2015
    • Table 2- 14: Distribution of Puskesmas (CHCs) in Indonesia across 34 Provinces
    • Hospital Classification in Indonesia
    • Table 2-15: Selected General and Specialty Hospitals in Indonesia
    • Private Healthcare System
    • Table 2-16: Selected Leading
    • Private Hospitals in Indonesia, by Province
    • Private Labs in Indonesia
    • Table 2-17: Selected Private Laboratories in Indonesia
  • Financial Aspects Of The Healthcare Industry In Indonesia
    • Table 2-18: Indonesia Healthcare Spending Compared to Southeast Asia Neighbors (New Zealand, Japan, Australia, South Korea,
    • Vietnam, China, Singapore, India, Malaysia, Thailand)
    • Table 2-19: Indonesia Healthcare Expenditure, 2000-2014 (Total Health Expenditure as % of GDP, Public Health Expenditure, Private Health Expenditure)
    • Implementation of UHC
    • Private Health Insurance
    • E-Catalogue Pricing System
    • Key Market Drivers Of The Indonesian Healthcare Market
  • Key Challenges In The Indonesian Healthcare Market
    • Uncertainty among Private Insurers
    • Rigid Reference Model Hampering Healthcare Accessibility
    • Limited Access to Quality Healthcare Facilities
    • Gap between Supply and Demand of Medical Professionals
    • Impact of the E-Catalogue Pricing System
    • Impact of Government’s Policies on Foreign Direct Investments (FDI)
    • Logistics Challenges
  • IVD Product Regulation In Indonesia
    • Table 2-20: Classification of Medical Devices
  • Important Factors To Consider While Choosing An Ivd Distributor In Indonesia
    • Trade-Off between Small and Big Distributors
    • Table 2-21: Selected Foreign Companies and Their Key Distributors in Indonesia
  • Processes For Distribution License, Company And Product Registrations
    • Company/Product Registration
    • Table 2-22: Licenses Required for IVD Distribution in Indonesia
  • Regulatory Trends And Insights Relevant For The IVD Sector
    • Market Transition to E-Catalogue and Related Regulations
    • Regulations For Foreign Direct Investments (FDI)
    • Table 2-23: Indonesia Investment Coordinating Board (BKPM) Offices
  • Setting Up A Company In Indonesia
    • Table 2-24: Options for a Foreign IVD Company to Enter the Indonesian Market
    • Assessing Option 1: Opening an Affiliated Branch Office in Indonesia
    • Assessing Option 2: Select a Suitable Exclusive Distributor
    • Assessing Option 3: Set up OEM Operations; Invest in Local Manufacturing within 3 years
  • Business Strategies Adopted By Multinational Companies (Mncs): Case Studies
    • Roche
    • bioMerieux
    • Thermo Fisher Scientific
    • Conclusion

3: IVD Market Analysis

  • Microbiology
  • LFIA Tests (Rapid Tests) for Infectious Diseases
    • Table 3-1: Sales of Rapid Tests for Infectious Diseases by Category, Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total)
    • Table 3-2: Popular Rapid Test Brands and Their Distributors in Indonesia
  • Lab-based Immunoassays for Infectious Diseases
    • Table 3-3: STD Test Costs at Selected Clinics and Hospitals in Indonesia
    • Table 3-4: Major Diseases and Demand for Lab-based Immunoassay Diagnostics in Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Lab-based Immunoassays - Infectious Diseases, Total) ID/AST
  • Molecular Diagnostics
    • Table 3-5: Microbiology Sales in Indonesia, 2017-2022 (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies, reagents, etc.]; Microbiology, Total)
  • Hematology
    • Table 3-6: List of Major Players in the Indonesian Hematology Market
    • Table 3-7: Hematology Sales by Category, Indonesia, 2017-2022 (Hematology Systems; Hematology POC; Other [Digital imaging, analysis software, etc.]; Hematology, Total)
  • Clinical Chemistry
    • Table 3-8: List of Major Players in the Indonesian Clinical Chemistry Market
    • Table 3-9: Clinical Chemistry Analyzer Sales by Category, Indonesia, 2017-2022 (General Chemistry; Blood Gas Analyzers; Critical Care POC; Clinical Chemistry, Total)
  • Point-Of-Care Tests
  • POC - OTC/ Self-Testing
  • POC - Professional-Testing
  • POC Hand-Held Devices
  • POC Bench-Top Analyzers
    • Table 3-10: POC Sales by Category, Indonesia, 2017-2022 (POC-Diabetes; POC-OTC/Self-Testing, Other; POC-OTC/Self Testing, Total; Cardiac Markers; DOA/Toxicology; Other; POC-Professional, Total; POC, Total)
  • Immunoassays
  • Point-of-Care (POC) Immunoassays
  • Immunoassays for Non-Infectious Diseases
    • Table 3-11: Immunoassay (Non-Infectious) Sales by Category, Indonesia, 2017-2022 (Diabetes; Cardiac markers; Other [Cancer Markers, DOA tests; cholesterol, RIAs for thyroid, hormones, endocrine markers, etc.]; Total, Lab-based Immunoassays - Non-Infectious; DOA testing - rapid tests; Cancer markers - Rapid tests; Cardiac markers - Rapid tests; Others [Pregnancy, Cancer markers, etc.]; Total, POC - Immunoassays - Non-Infectious; Total - Immunoassays - Non-Infectious)
  • Blood Testing And Typing
    • Table 3-12: Distribution of Blood Centers in Indonesia, by Province
  • Non-Standardized Evaluation Protocol
    • Table 3-13: Blood Testing and Typing Sales by Category (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT), Indonesia, 2017-2022
  • Urinalysis
    • Table 3-14: List of Major Players in the Indonesian Urinalysis Market
  • Coagulation
    • Table 3-15: List of Major Players in the Indonesian Coagulation Market
    • Table 3-16: Hemostasis Sales by Category (Lab-based Coagulation Tests, POC Coagulation Tests), Indonesia, 2017-2022
  • Histology
    • Table 3-17: List of Major Players in the Indonesian Histology Market
    • Table 3-18: Histology Sales by Category (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC, and Flow Cytometry]), Indonesia, 2017-2022
  • Total IVD Markets In Indonesia
    • Table 3-19: Total IVD Market in Indonesia by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays - Non-Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.]), 2017-2022

4: IVD Companies, Private Labs And Distributor Profiles

  • IVD Company Profiles
    • Abbott Laboratories
    • Alere
    • Arkray Healthcare
    • Beckman Coulter
    • Becton, Dickinson and Company (BD)
    • bioMerieux
    • Bio-Rad
    • Cellavision
    • Cepheid
    • Critical Diagnostics
    • DiaSorin S.p.A.
    • EKF Diagnostics
    • ERBA Diagnostics
    • HemoCue AB
    • Hologic, Inc.
    • Horiba, Ltd.
    • Instrumentation Laboratory Company
    • Luminex Corporation
    • Mindray Medical International Limited
    • Nihon Kohden Corporation
    • Ortho Clinical Diagnostics
    • Qiagen N.V.
    • Radiometer Medical ApS
    • Randox Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Tosoh Corporation
    • Trinity Biotech
  • Leading Private Labs In Indonesia
    • Laboratorium Klinik Utama Bio Medika
    • PT Cito Putra Utama
    • PT Kimia Farma Diagnostika
    • Laboratorium Klinik Pramita
    • PT Prodia Widyahusada Tbk
    • Profiles Of Selected Ivd Distributors In Indonesia
    • Table 4-1: Profiles of Selected IVD Distributors in Indonesia
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Alere
  • Arkray Healthcare
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Bio-Rad
  • Cellavision
  • Cepheid
  • Critical Diagnostics
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • ERBA Diagnostics
  • HemoCue AB
  • Hologic, Inc.
  • Horiba, Ltd.
  • Instrumentation Laboratory Company
  • Laboratorium Klinik Utama Bio Medika
  • Luminex Corporation
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Ortho Clinical Diagnostics
  • PT Cito Putra Utama
  • PT Kimia Farma Diagnostika
  • PT Prodia Widyahusada TBK
  • Qiagen N.V.
  • Radiometer Medical ApS
  • Randox Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation
  • Trinity Biotech
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll